Next Article in Journal
Carbon Fiber Implants in Orthopaedic Oncology
Next Article in Special Issue
Blood Pressure Targets for Out-of-Hospital Cardiac Arrest: A Systematic Review and Meta-Analysis
Previous Article in Journal
Healthcare-Associated Infective Endocarditis—Surgical Perspectives
 
 
Article
Peer-Review Record

Inodilators May Improve the In-Hospital Mortality of Patients with Cardiogenic Shock Undergoing Veno-Arterial Extracorporeal Membrane Oxygenation

J. Clin. Med. 2022, 11(17), 4958; https://doi.org/10.3390/jcm11174958
by Mijoo Kim 1, Seok-Woo Seong 1, Pil Sang Song 1, Jin-Ok Jeong 1, Jeong Hoon Yang 2, Hyeon-Cheol Gwon 2, Young-Guk Ko 3, Cheol Woong Yu 4, Woo Jung Chun 5, Woo Jin Jang 6, Hyun-Joong Kim 7, Jang-Whan Bae 8, Sung Uk Kwon 9, Hyun-Jong Lee 10, Wang Soo Lee 11, Sang-Don Park 12, Sung Soo Cho 13 and Jae-Hyeong Park 1,*
Reviewer 1:
Reviewer 2: Anonymous
Reviewer 3: Anonymous
J. Clin. Med. 2022, 11(17), 4958; https://doi.org/10.3390/jcm11174958
Submission received: 11 July 2022 / Revised: 22 August 2022 / Accepted: 23 August 2022 / Published: 24 August 2022

Round 1

Reviewer 1 Report

Interesting conclusions with the adequate cautions regarding the fact that this study is observational, with some missing details : i.e dosage of inodilators, type of inodilators effectively used.

Author Response

Point 1: Interesting conclusions with the adequate cautions regarding the fact that this study is observational, with some missing details : i.e dosage of inodilators, type of inodilators effectively used.

Response: Thank you for your comment.

Reviewer 2 Report

Manuscript Number: JCM-1834777

Title: The use of inodilators may improve in-hospital mortality inpatients with cardiogenic shock underwent veno-arterial extracorporeal membrane oxygenation.

Author: Mijoo Kim, etc.

 

1.    General Comments 

 

This manuscript, the author investigated inotropes use may improve clinical outcomes in refractory CS patients with VA-ECMO.  There is some limitations in this paper, but it is mentioned in the discussion, and there are no additional corrections or remarks from me.

 

Author Response

Point 1: This manuscript, the author investigated inotropes use may improve clinical outcomes in refractory CS patients with VA-ECMO.  There is some limitations in this paper, but it is mentioned in the discussion, and there are no additional corrections or remarks from me.

Response: Thank you for your comment. Actually, we did English editing before the submission. But, we have made extensive English editing again from a native speaker.

Reviewer 3 Report

Dear Sir/Madam,

 

I had the opportunity to act as a reviewer on the recent submission by Kim et al. to the Journal of Clinical Medicine.

The authors present original research studying the effect of inodilators on clinical outcomes in a mixed patient cohort (registry, observational) with cardiogenic shock undergoing VA-ECMO. They found that use of inodilators was significantly associated with lower in-hospital mortality.

The manuscript is well structured; however, some issues need to be addressed:

 

  1. I recommend extensive editing of English language and style, ideally by native speaker.
  2. Please provide a clear definition of cardiogenic shock. The lines 85-88 read rather as inclusion criteria.
  3. Regarding tables 1 and 3: what does exactly “unloading of left ventricle” mean – the use of a percutaneous microaxial pump (i.e., Impella)? Please comment.

 

 

Best regards,

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Back to TopTop